Selective efficacy and safety of first line and non front line antineoplasic agent combinations determined with individualized assays on colorectal cancer primary cultures.

Added 480 days ago (22.01.2021)
Authors: N Garza-Trevino E, G Martínez Rodríguez H, S Rodríguez González M, Delgado González P, F González Guerrero J, S García González I, Flores Gutiérrez JP, Soto Domínguez A, Said Fernández S
PubMed id: 32277633
Read article